DOI:
10.1055/s-00029025
Journal of Pediatric Epilepsy
LinksClose Window
References
Tolman JA, Faulkner MA.
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.
Expert Opin Pharmacother 2009;
10 (18) 3077-3089
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.